Nanoparticles for ocular drug delivery: modified and non-modified chitosan as a promising biocompatible carrier

被引:34
作者
Pontillo, Antonella Rozaria Nefeli [1 ]
Detsi, Anastasia [1 ]
机构
[1] Natl Tech Univ Athens, Sch Chem Engn, Lab Organ Chem, Iroon Politech 9, Athens 15780, Greece
关键词
combined nanocarriers; dual systems; modified chitosan nanoparticles; ophthalmic drug delivery; sustained release; DEXTRAN SULFATE NANOPARTICLES; IN-VITRO; MUCOADHESIVE PROPERTIES; MOLECULAR-WEIGHT; HYALURONIC-ACID; SMART CARRIERS; DERIVATIVES; SYSTEMS; NANO; EYE;
D O I
10.2217/nnm-2019-0040
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The eye is a very important, yet sensitive organ, presenting complex anatomy. To overcome its protective mechanisms, with the aim of improving drug delivery, drug encapsulation in nanocarriers is considered in this review. Chitosan is found to be an excellent drug carrier and its application in ophthalmology is being extensively researched. This mucoadhesive biopolymer can protect the encapsulated molecule, optimize its mode of action and minimize any existent risk. Moreover, chitosan and its derivatives may provide advantageous properties to the system such as thermoresponsivity and pH dependency. Finally, dual systems of chitosan with other carriers, such as poly (lactic-co-glycolic acid) and alginate, are also mentioned in this review, as they may offer additional benefits such as higher permeation due to different interaction of each carrier with the corneal layers.
引用
收藏
页码:1889 / 1909
页数:21
相关论文
共 87 条
  • [1] Recent advances on chitosan-based micro- and nanoparticles in drug delivery
    Agnihotri, SA
    Mallikarjuna, NN
    Aminabhavi, TM
    [J]. JOURNAL OF CONTROLLED RELEASE, 2004, 100 (01) : 5 - 28
  • [2] In situ gel systems as 'smart' carriers for sustained ocular drug delivery
    Agrawal, Ashish Kumar
    Das, Manasmita
    Jain, Sanyog
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2012, 9 (04) : 383 - 402
  • [3] Nanoparticle-loaded hydrogels as a pathway for enzyme-triggered drug release in ophthalmic applications
    Ahlen, Michelle
    Tummala, Gopi Krishna
    Mihranyan, Albert
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 536 (01) : 73 - 81
  • [4] [Anonymous], 2016, ADV DRUG DELIV REV A
  • [5] Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases
    Bachu, Rinda Devi
    Chowdhury, Pallabitha
    Al-Saedi, Zahraa H. F.
    Karla, Pradeep K.
    Boddu, Sai H. S.
    [J]. PHARMACEUTICS, 2018, 10 (01)
  • [6] Chitosan nanoparticles for ocular delivery of cyclosporine A
    Basaran, Ebru
    Yenilmez, Evrim
    Berkman, Murat Sami
    Buyukkoroglu, Gulay
    Yazan, Yasemin
    [J]. JOURNAL OF MICROENCAPSULATION, 2014, 31 (01) : 49 - 57
  • [7] Ocular application of chitosan
    Basaran, Ebru
    Yazan, Yasemin
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2012, 9 (06) : 701 - 712
  • [8] Synthesis and Characterization of Poly(2-hydroxyethylmethacrylate) Contact Lenses Containing Chitosan Nanoparticles as an Ocular Delivery System for Dexamethasone Sodium Phosphate
    Behl, Gautam
    Iqbal, Javed
    O'Reilly, Niall J.
    McLoughlin, Peter
    Fitzhenry, Laurence
    [J]. PHARMACEUTICAL RESEARCH, 2016, 33 (07) : 1638 - 1648
  • [9] Chitosan-based drug delivery systems
    Bernkop-Schnuerch, Andreas
    Duennhaupt, Sarah
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2012, 81 (03) : 463 - 469
  • [10] Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: In vitro and pharmacokinetics studies
    Bhatta, R. S.
    Chandasana, H.
    Chhonker, Y. S.
    Rathi, C.
    Kumar, D.
    Mitra, K.
    Shukla, P. K.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 432 (1-2) : 105 - 112